会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES
    • 新型双相杂环化合物的抗病毒活性
    • WO2011147753A1
    • 2011-12-01
    • PCT/EP2011/058276
    • 2011-05-20
    • KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&DDE JONGHE, StevenGAO, Ling-JieHERDEWIJN, PietHERMAN, JeanJANG, MiyeonLEYSSEN, PieterLOUAT, ThierryNEYTS, JohanPANNECOUQUE, ChristopheVANDERHOYDONCK, Bart
    • DE JONGHE, StevenGAO, Ling-JieHERDEWIJN, PietHERMAN, JeanJANG, MiyeonLEYSSEN, PieterLOUAT, ThierryNEYTS, JohanPANNECOUQUE, ChristopheVANDERHOYDONCK, Bart
    • A61P31/12A61P31/14A61P31/16A61P31/18A61K31/519A61K31/52A61K31/551
    • A61K31/551A61K31/519A61K31/52A61K31/5377C07D473/00C07D513/04Y02A50/385Y02A50/465
    • The present invention relates to compound of Formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1 or as described in detail in the description of the invention, and to the use of said compounds to treat or prevent viral infections and their use to manufacture a medicine to treat or prevent viral infections, particularly infections with RNA-viruses belonging to the family of the Retroviridae, the family of the Flaviviridae and the family of the Picornaviridae and more preferably infections with Human Immunodeficiency Virus 1 (HIV1), Human Immunodeficiency Virus 2 (HIV2), Hepatitis C virus (HCV), Dengue virus, and enteroviruses like Coxsackievirus, Rhinovirus and Poliovirus. The present invention also relates to pharmaceutical compositions of said compounds and the use of said pharmaceutical compositions to treat or prevent viral infections. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of viral disorders and pathologic conditions such as, but not limited to, viral infections with Human Immunodeficiency Virus 1 (HIV1), Human Immunodeficiency Virus 2 (HIV2), Hepatitis C virus (HCV), Dengue virus, and enteroviruses like Coxsackievirus, Rhinovirus and Poliovirus.
    • 本发明涉及式I,II,III或IV化合物和/或其药学上可接受的加成盐和/或其立体异构体和/或其溶剂合物,其中R1,R2,R3,R4,R5, R6,R7,R8,R9,R11和R12如权利要求1中所定义或如在本发明的描述中详细描述的,以及所述化合物用于治疗或预防病毒感染及其用于制造 治疗或预防病毒感染的药物,特别是属于逆转录病毒科的家族,微病毒科的家族和小核糖核酸病毒科家族的RNA病毒的感染,更优选人免疫缺陷病毒1(HIV1),人类免疫缺陷病毒2 (HIV2),丙型肝炎病毒(HCV),登革热病毒和诸如柯萨奇病毒,鼻病毒和脊髓灰质炎病毒的肠道病毒。 本发明还涉及所述化合物的药物组合物和所述药物组合物用于治疗或预防病毒感染的用途。 本发明还涉及所述化合物作为生物活性成分的用途,更具体地说,作为治疗病毒性病症和病理状况的药物,例如但不限于人免疫缺陷病毒1(HIV1),人类免疫缺陷病毒 病毒2(HIV2),丙型肝炎病毒(HCV),登革热病毒和诸如柯萨奇病毒,鼻病毒和脊髓灰质炎病毒的肠道病毒。